These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
115 related articles for article (PubMed ID: 170010)
1. [Interconvertibility of molecular forms of 3'5' cyclic AMP phosphodiesterase of human platelets]. Pichard AL; Kaplan JC C R Acad Hebd Seances Acad Sci D; 1975 Feb; 280(5):673-6. PubMed ID: 170010 [TBL] [Abstract][Full Text] [Related]
2. Effect of N-2, 2'-O-dibutyryl cyclic AMP upon the interconvertible forms of cyclic AMP phosphodiesterase from human platelets. Pichard AL; Kaplan JC Biochem Biophys Res Commun; 1975 May; 64(1):342-6. PubMed ID: 167738 [No Abstract] [Full Text] [Related]
3. Cyclid 3':5'-nucleotide phosphodiesterase. Interconvertible multiple forms and their effects on enzyme activity and kinetics. Pichard AL; Cheung WY J Biol Chem; 1976 Sep; 251(18):5726-37. PubMed ID: 184086 [TBL] [Abstract][Full Text] [Related]
4. Platelet cyclic 3':5'-nucleotide phosphodiesterase released by thrombin and calcium ionophore. Hidaka H; Asano T J Biol Chem; 1976 Dec; 251(23):7508-16. PubMed ID: 187590 [TBL] [Abstract][Full Text] [Related]
5. Human blood platelet 3': 5'-cyclic nucleotide phosphodiesterase. Isolation of low-Km and high-Km phosphodiesterase. Hidaka H; Asano T Biochim Biophys Acta; 1976 Apr; 429(2):485-97. PubMed ID: 177073 [TBL] [Abstract][Full Text] [Related]
6. 3',5' Cyclic nucleotide phosphodiesterase from human platelets: effect of heat upon the multiple forms and their interconversion. Pichard AL; Choury D; Kaplan JC Biochimie; 1981 Jul; 63(7):603-9. PubMed ID: 6269658 [TBL] [Abstract][Full Text] [Related]
7. Selective inhibitors of three forms of cyclic nucleotide phosphodiesterase--basic and potential clinical applications. Hidaka H; Endo T Adv Cyclic Nucleotide Protein Phosphorylation Res; 1984; 16():245-59. PubMed ID: 6144253 [No Abstract] [Full Text] [Related]
8. Studies with phosphodiesterase. 3. Two forms of the enzyme from human blood platelets. Amer MS; Mayol RF Biochim Biophys Acta; 1973 May; 309(1):149-56. PubMed ID: 4350749 [No Abstract] [Full Text] [Related]
9. Characterisation of cyclic adenosine 3':5'-monophosphate phospodiesterase from Walker carcinoma sensitive and resistant to bifunctional alkylating agents. Tisdale MJ Biochim Biophys Acta; 1975 Jul; 397(1):134-43. PubMed ID: 238630 [TBL] [Abstract][Full Text] [Related]
12. Hydrolysis of guanosine and adenosine 3',5'-monophosphates by rat blood. Patterson WD; Hardman JG; Sutherland EW Biochim Biophys Acta; 1975 Mar; 384(1):159-67. PubMed ID: 165831 [TBL] [Abstract][Full Text] [Related]
13. Cyclic nucleotide phosphodiesterase activities from pig coronary arteries. Lack of interconvertibility of major forms. Keravis TM; Wells JN; Hardman JG Biochim Biophys Acta; 1980; 613(1):116-29. PubMed ID: 6246952 [TBL] [Abstract][Full Text] [Related]
14. PDE2 inhibition by the PI3 kinase inhibitor LY294002 and analogues. Abbott BM; Thompson PE Bioorg Med Chem Lett; 2004 Jun; 14(11):2847-51. PubMed ID: 15125945 [TBL] [Abstract][Full Text] [Related]
15. Human thyroid cyclic nucleotide phosphodiesterase. Its characterization and the effect of several hormones on the activity. Nagasaka A; Hidaka H Biochim Biophys Acta; 1976 Jul; 438(2):449-60. PubMed ID: 182233 [TBL] [Abstract][Full Text] [Related]